We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300661:SZSESG Micro Corp. Class A Analysis

Data as of 2026-05-18 - not real-time

CN¥105.35

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading well above its moving averages, with the short‑term average sitting above the medium and long averages, reinforcing a bullish trend. Momentum indicators show the RSI perched in the overbought zone while the MACD line sits comfortably above its signal, producing a bullish histogram. Volume has remained stable, supporting the price advance.
Fundamentally, revenue is expanding at a robust pace and margins remain healthy, yet the price‑earnings multiple is dramatically higher than the industry norm, and the discounted cash flow estimate sits far below the current market level. The company carries modest debt relative to equity but free cash flow is negative, raising questions about cash generation sustainability. Dividend yield is minimal and the payout ratio, while low, is backed by limited free cash.
Market sentiment is extremely greedy according to the fear‑greed gauge, and the stock’s beta is low, suggesting limited systematic risk, but volatility is high, pointing to price swings. Given the combination of strong technical momentum, stretched valuation, and elevated volatility, investors should weigh short‑term upside against the risk of a valuation correction.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (SMA alignment, MACD crossover)
  • Significant valuation premium over peers
  • Elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth and healthy margins
  • Continued overvaluation relative to fundamentals
  • Potential for valuation correction amid high volatility

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Sustained industry tailwinds in semiconductors
  • Modest debt profile but negative free cash flow
  • Uncertain dividend sustainability and valuation gap

Key Metrics & Analysis

Financial Health

Revenue Growth39.10%
Profit Margin14.52%
P/E Ratio107.5
ROE11.90%
ROA4.90%
Debt/Equity10.07
P/B Ratio12.0
Op. Cash FlowCN¥422.3M
Free Cash FlowCN¥-172602112
Industry P/E38.2

Technical Analysis

TrendBullish
RSI73.5
SupportCN¥75.20
ResistanceCN¥113.90
MA 20CN¥91.01
MA 50CN¥79.41
MA 200CN¥74.49
MACDBullish
VolumeStable
Fear & Greed Index89.68

Valuation

Fair ValueCN¥20.68
Target PriceCN¥92.72
Upside/Downside-11.99%
GradeOvervalued
TypeGrowth
Dividend Yield0.19%

Risk Assessment

Beta0.44
Volatility55.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.